Pathos Company
Pathos is at the forefront of a novel approach to AI-driven drug development. This approach harnesses multimodal data, cutting-edge Artificial Intelligence, and profound clinical understanding to expedite the introduction of new therapies for patients. With an emphasis on Artificial Intelligence, clinical development, and implementation, Pathos is dedicated to enhancing patient outcomes by speeding up the transition from molecule to medicine.
Technology:
Computational Drug Design & Virtual Screening
Industry:
BioPharma AI
Funding Status:
private
Headquarters:
Chicago,Illinois,United States,North America
Founded Date:
2020-01-01 00:00:00

